By: Alvaro Fernandez
We are proud to add a new pioneering perspective to the already impressive Speaker Roster at the upcoming 2016 SharpBrains Virtual Summit: Reinventing Brain Health in the Digital Age (December 6-8th).
Sanjiv Rai, named a Young Global Leader by the World Economic Forum and founder of Genic.ai, will discuss How Artificial Intelligence (AI) enables truly Personalized Health: tracing behaviors and deep patterns. You should know that his firm’s artificial intelligence system, while originally designed to improve healthcare, has accurately predicted Read the rest of this entry »
Time for a new edition of SharpBrains’ e-newsletter, exploring a range of technologies, scientific findings and insights for brain health and mental health to better respond to the opportunities and challenges ahead.
Happy reading, and Happy Thanksgiving!
Finally, we are delighted to announce five new excellent Speakers at the upcoming 2016 SharpBrains Virtual Summit: Reinventing Brain Health in the Digital Age (December 6-8, 2016):
- Mary Stuart, Senior Writer/Analyst at The MedTech Strategist
- Dr. Andrea Serino, Head of Neuroscience at MindMaze
- Linda Raines, CEO of the Mental Health Association of Maryland
- Karen Olsen, Executive Director of the Center for the Future of Public Education
- David Coleiro, Partner at Strategic North
You can explore the Summit Agenda here, and Register here. Please consider joining us and help reinvent brain health in the digital age!
The SharpBrains Team
How Are Direct-to-Consumer-Advertisements Changing Psychiatric Drug Use? (The Dana Foundation):
“Flip on your television to a commercial station and you are likely to see ads for cars, snacks, and home appliances—and prescription medications. Some ads specifically target psychiatric illnesses Read the rest of this entry »
Time for a new edition of SharpBrains’ e-newsletter. Happy reading!
Recent & Upcoming events:
Finally, here you have a fun visual illusion — What do you see?
Have a great Halloween and month of November,
The SharpBrains Team
Click Therapeutics™ Reports Preliminary Results of a 416-Participant Clinical Study Demonstrating Exceptional Engagement and Efficacy of Clickotine®, a Patent-Pending Digital Therapeutics™ Program for Smoking Cessation (press release):
“Click Therapeutics, Inc. (“Click”), a company developing a suite of personalized data-driven digital therapeutics for chronic health conditions, announces today preliminary results of its fully remote clinical trial of Clickotine, a digital program designed for smoking cessation. Read the rest of this entry »